Meetings To Implement Pandemic Response Voluntary Agreement Under Section 708 of the Defense Production Act, 784-785 [2021-28596]
Download as PDF
784
Federal Register / Vol. 87, No. 4 / Thursday, January 6, 2022 / Notices
II Proposal Title: Optimized Dry Powder
Formulation and Delivery for Inhaled
Clofazimine (N01).
Date: January 27, 2022.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Cynthia L. De La Fuente,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20852, 240–669–2740,
delafuentecl@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 30, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–00008 Filed 1–5–22; 8:45 am]
BILLING CODE 4140–01–P
National Institute of Allergy and
Infectious Diseases Notice of Closed
Meeting
TKELLEY on DSK125TN23PROD with NOTICE
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC–SBIR PHS
2022–1: Development of Diagnostics to
Differentiate HIV Infection from Vaccine
Induced Seropositivity (Topic 103).
Date: February 2, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22B,
Rockville, MD 20892 (Virtual Meeting).
Jkt 256001
[FR Doc. 2022–00009 Filed 1–5–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2020–0016]
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Announcement of meetings.
AGENCY:
National Institutes of Health
18:13 Jan 05, 2022
Dated: December 30, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
Meetings To Implement Pandemic
Response Voluntary Agreement Under
Section 708 of the Defense Production
Act
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Contact Person: Kristina S. Wickham,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22B,
Rockville, MD 20852, 301–761–5390,
kristina.wickham@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
The Federal Emergency
Management Agency (FEMA) is holding
a series of meetings, under the Plan of
Action to Establish a National Strategy
for the Coordination of National
Multimodal Healthcare Supply Chains
to Respond to COVID–19, to implement
the Voluntary Agreement for the
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
Respond to a Pandemic.
DATES:
• Wednesday, January 5, 2022, from 1
p.m. to 3 p.m. Eastern Time (ET).
• Wednesday, January 12, 2022, from
1 p.m. to 3 p.m. ET.
• Wednesday, January 19, 2022, from
1 p.m. to 3 p.m. ET.
• Wednesday, January 26, 2022, from
1 p.m. to 3 p.m. ET.
FOR FURTHER INFORMATION CONTACT:
Robert Glenn, Office of Business,
Industry, Infrastructure Integration, via
email at OB3I@fema.dhs.gov or via
phone at (202) 212–1666.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is provided as required
by section 708(h)(8) of the Defense
Production Act (DPA), 50 U.S.C.
4558(h)(8), and consistent with 44 CFR
part 332.
SUMMARY:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
The DPA authorizes the making of
‘‘voluntary agreements and plans of
action’’ with representatives of industry,
business, and other interests to help
provide for the national defense.1 The
President’s authority to facilitate
voluntary agreements with respect to
responding to the spread of COVID–19
within the United States was delegated
to the Secretary of Homeland Security
in Executive Order 13911.2 The
Secretary of Homeland Security further
delegated this authority to the FEMA
Administrator.3
On August 17, 2020, after the
appropriate consultations with the
Attorney General and the Chairman of
the Federal Trade Commission, FEMA
completed and published in the Federal
Register a ‘‘Voluntary Agreement,
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
Respond to a Pandemic’’ (Voluntary
Agreement).4 Unless terminated earlier,
the Voluntary Agreement is effective
until August 17, 2025, and may be
extended subject to additional approval
by the Attorney General after
consultation with the Chairman of the
Federal Trade Commission. The
Agreement may be used to prepare for
or respond to any pandemic, including
COVID–19, during that time.
On December 7, 2020, the first plan of
action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Personal Protective
Equipment (PPE) to Respond to COVID–
19 (PPE Plan of Action)—was finalized.5
The PPE Plan of Action established
several sub-committees under the
Voluntary Agreement, focusing on
different aspects of the PPE Plan of
Action.
On May 24, 2021, four additional
plans of action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Diagnostic Test Kits and
other Testing Components to respond to
COVID–19, the Plan of Action to
1 50
U.S.C. 4558(c)(1).
FR 18403 (Apr. 1, 2020).
3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020);
DHS Delegation Number 09052 Rev. 00 (Jan. 3,
2017).
4 85 FR 50035 (Aug. 17, 2020). The Attorney
General, in consultation with the Chairman of the
Federal Trade Commission, made the required
finding that the purpose of the voluntary agreement
may not reasonably be achieved through an
agreement having less anticompetitive effects or
without any voluntary agreement and published the
finding in the Federal Register on the same day. 85
FR 50049 (Aug. 17, 2020).
5 See 85 FR 78869 (Dec. 7, 2020). See also 85 FR
79020 (Dec. 8, 2020).
2 85
E:\FR\FM\06JAN1.SGM
06JAN1
TKELLEY on DSK125TN23PROD with NOTICE
Federal Register / Vol. 87, No. 4 / Thursday, January 6, 2022 / Notices
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Drug Products, Drug
Substances, and Associated Medical
Devices to respond to COVID–19, the
Plan of Action to Establish a National
Strategy for the Manufacture,
Allocation, and Distribution of Medical
Devices to respond to COVID–19, and
the Plan of Action to Establish a
National Strategy for the Manufacture,
Allocation, and Distribution of Medical
Gases to respond to COVID–19—were
finalized.6 These plans of action
established several sub-committees
under the Voluntary Agreement,
focusing on different aspects of each
plan of action.
On October 15, 2021, the sixth plan of
action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Coordination of National Multimodal
Healthcare Supply Chains to Respond to
COVID–19—was finalized.7 This plan of
action established several subcommittees under the Voluntary
Agreement, focusing on different
transportation categories.
The meetings are chaired by the
FEMA Administrator’s delegates from
the Office of Response and Recovery
(ORR) and Office of Policy and Program
Analysis (OPPA), attended by the
Attorney General’s delegates from the
U.S. Department of Justice, and attended
by the Chairman of the Federal Trade
Commission’s delegates. In
implementing the Voluntary Agreement,
FEMA adheres to all procedural
requirements of 50 U.S.C. 4558 and 44
CFR part 332.
Meeting Objectives: The objectives of
the meetings are as follows:
1. Convene the Sub-Committee to
Define Requirements under the National
Multimodal Healthcare Supply Chains
Plan of Action to establish priorities
related to the COVID–19 response under
the Voluntary Agreement.
2. Gather Sub-Committee Participants
and Attendees to ask targeted questions
for situational awareness.
3. Identify pandemic-related supply
chain issues, information gaps, and
areas for potential additional
discussion.
4. Identify potential Objectives and
Actions which correspond to SubCommittees. These will be held for
further discussion under those SubCommittees.
Meetings Closed to the Public: By
default, the DPA requires meetings held
to implement a voluntary agreement or
plan of action be open to the public.8
However, attendance may be limited if
the Sponsor 9 of the voluntary
agreement finds that the matter to be
discussed at a meeting falls within the
purview of matters described in 5 U.S.C.
552b(c), such as trade secrets and
commercial or financial information.
The Sponsor of the Voluntary
Agreement, the FEMA Administrator,
found that these meetings to implement
the Voluntary Agreement involve
matters which fall within the purview of
matters described in 5 U.S.C. 552b(c)
and the meetings are therefore closed to
the public.
Specifically, these meetings may
require participants to disclose trade
secrets or commercial or financial
information that is privileged or
confidential. Disclosure of such
information allows for meetings to be
closed to the public pursuant to 5 U.S.C.
552b(c)(4).
The success of the Voluntary
Agreement depends wholly on the
willing participation of the private
sector participants. Failure to close
these meetings to the public could
reduce active participation by the
signatories due to a perceived risk that
sensitive company information could be
released to the public. A public
disclosure of a private sector
participant’s information executed
prematurely could reduce trust and
support for the Voluntary Agreement.
A resulting loss of support by the
participants for the Voluntary
Agreement would significantly hinder
the implementation of the Agency’s
objectives. Thus, these meeting closures
are permitted pursuant to 5 U.S.C.
552b(c)(9)(B).
Deanne Criswell,
Administrator, Federal Emergency
Management Agency.
[FR Doc. 2021–28596 Filed 1–5–22; 8:45 am]
BILLING CODE 9111–19–P
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[LLNMF000000.L14400000.ET0000
LXSSG0270000 223L1109AF; NMNM–
144042]
Notice of Proposed Withdrawal and
Public Meetings; San Juan County, NM
AGENCY:
Bureau of Land Management,
Interior.
8 See
50 U.S.C. 4558(h)(7).
individual designated by the President in
subsection (c)(2) [of section 708 of the DPA] to
administer the voluntary agreement, or plan of
action.’’ 50 U.S.C. 4558(h)(7).
9 ‘‘[T]he
6 See 86 FR 27894 (May 24, 2021). See also 86 FR
28851 (May 28, 2021).
7 See 86 FR 57444 (Oct. 15, 2021).
VerDate Sep<11>2014
18:13 Jan 05, 2022
Jkt 256001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
ACTION:
785
Notice of proposed withdrawal.
At the request of the Bureau
of Land Management (BLM) and subject
to valid existing rights, the Secretary of
the Interior proposes to withdraw
351,479.97 acres of public lands from
location and entry under the United
States mining laws and from leasing
under the mineral leasing laws, but not
disposal under the mineral materials
laws, for a 20-year term. This notice
segregates the lands for up to 2 years
from location and entry under the
United States mining laws and from
leasing under the mineral leasing laws,
subject to valid existing rights, initiates
a 90-day public comment period on the
withdrawal application, and notifies the
public that one or more public meetings
will be held regarding the application.
DATES: Comments and public meeting
requests must be received by April 6,
2022. In-person public meetings
regarding the withdrawal application
will be held on February 23, 2022, from
3:00–4:30 p.m. and 6:00–7:30 p.m. at
San Juan College Henderson Fine Arts
Building, 4601 College Boulevard,
Farmington, New Mexico. All current
guidelines issued by the Centers for
Disease Control and Prevention and
Department of the Interior COVID–19
safety precautions will be strictly
enforced. Members of the public are
required to pre-register for the in-person
event by using the information provided
in the FOR FURTHER INFORMATION
CONTACT section of this notice. A virtual
public meeting will take place on
February 24 from 6:00–7:30 p.m. via the
Zoom platform. To register for the
virtual session, visit https://
blm.zoomgov.com/webinar/register/
WN_79HAmxoxQ-GXRVRBXl5U0w. A
notice for public meeting(s) regarding
the withdrawal application will be
announced in the local newspaper and
on the agency websites at least 30 days
before the meeting(s).
ADDRESSES: All comments should be
sent to Sarah Scott, CCNHP Area
Withdrawal, Bureau of Land
Management Farmington Field Office,
6251 College Blvd. Suite A, Farmington,
NM 87402.
A map and other information related
to the withdrawal application are
available at the Bureau of Land
Management Farmington Field Office,
6251 College Blvd., Suite A,
Farmington, New Mexico 87402. Details
are also available on the project
ePlanning website: https://
eplanning.blm.gov/eplanning-ui/
project/2016892/510.
FOR FURTHER INFORMATION CONTACT:
Sarah Scott, BLM Farmington Field
SUMMARY:
E:\FR\FM\06JAN1.SGM
06JAN1
Agencies
[Federal Register Volume 87, Number 4 (Thursday, January 6, 2022)]
[Notices]
[Pages 784-785]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28596]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HOMELAND SECURITY
Federal Emergency Management Agency
[Docket ID FEMA-2020-0016]
Meetings To Implement Pandemic Response Voluntary Agreement Under
Section 708 of the Defense Production Act
AGENCY: Federal Emergency Management Agency, Department of Homeland
Security.
ACTION: Announcement of meetings.
-----------------------------------------------------------------------
SUMMARY: The Federal Emergency Management Agency (FEMA) is holding a
series of meetings, under the Plan of Action to Establish a National
Strategy for the Coordination of National Multimodal Healthcare Supply
Chains to Respond to COVID-19, to implement the Voluntary Agreement for
the Manufacture and Distribution of Critical Healthcare Resources
Necessary to Respond to a Pandemic.
DATES:
Wednesday, January 5, 2022, from 1 p.m. to 3 p.m. Eastern
Time (ET).
Wednesday, January 12, 2022, from 1 p.m. to 3 p.m. ET.
Wednesday, January 19, 2022, from 1 p.m. to 3 p.m. ET.
Wednesday, January 26, 2022, from 1 p.m. to 3 p.m. ET.
FOR FURTHER INFORMATION CONTACT: Robert Glenn, Office of Business,
Industry, Infrastructure Integration, via email at [email protected] or
via phone at (202) 212-1666.
SUPPLEMENTARY INFORMATION: Notice of these meetings is provided as
required by section 708(h)(8) of the Defense Production Act (DPA), 50
U.S.C. 4558(h)(8), and consistent with 44 CFR part 332.
The DPA authorizes the making of ``voluntary agreements and plans
of action'' with representatives of industry, business, and other
interests to help provide for the national defense.\1\ The President's
authority to facilitate voluntary agreements with respect to responding
to the spread of COVID-19 within the United States was delegated to the
Secretary of Homeland Security in Executive Order 13911.\2\ The
Secretary of Homeland Security further delegated this authority to the
FEMA Administrator.\3\
---------------------------------------------------------------------------
\1\ 50 U.S.C. 4558(c)(1).
\2\ 85 FR 18403 (Apr. 1, 2020).
\3\ DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); DHS
Delegation Number 09052 Rev. 00 (Jan. 3, 2017).
---------------------------------------------------------------------------
On August 17, 2020, after the appropriate consultations with the
Attorney General and the Chairman of the Federal Trade Commission, FEMA
completed and published in the Federal Register a ``Voluntary
Agreement, Manufacture and Distribution of Critical Healthcare
Resources Necessary to Respond to a Pandemic'' (Voluntary
Agreement).\4\ Unless terminated earlier, the Voluntary Agreement is
effective until August 17, 2025, and may be extended subject to
additional approval by the Attorney General after consultation with the
Chairman of the Federal Trade Commission. The Agreement may be used to
prepare for or respond to any pandemic, including COVID-19, during that
time.
---------------------------------------------------------------------------
\4\ 85 FR 50035 (Aug. 17, 2020). The Attorney General, in
consultation with the Chairman of the Federal Trade Commission, made
the required finding that the purpose of the voluntary agreement may
not reasonably be achieved through an agreement having less
anticompetitive effects or without any voluntary agreement and
published the finding in the Federal Register on the same day. 85 FR
50049 (Aug. 17, 2020).
---------------------------------------------------------------------------
On December 7, 2020, the first plan of action under the Voluntary
Agreement--the Plan of Action to Establish a National Strategy for the
Manufacture, Allocation, and Distribution of Personal Protective
Equipment (PPE) to Respond to COVID-19 (PPE Plan of Action)--was
finalized.\5\ The PPE Plan of Action established several sub-committees
under the Voluntary Agreement, focusing on different aspects of the PPE
Plan of Action.
---------------------------------------------------------------------------
\5\ See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 79020 (Dec.
8, 2020).
---------------------------------------------------------------------------
On May 24, 2021, four additional plans of action under the
Voluntary Agreement--the Plan of Action to Establish a National
Strategy for the Manufacture, Allocation, and Distribution of
Diagnostic Test Kits and other Testing Components to respond to COVID-
19, the Plan of Action to
[[Page 785]]
Establish a National Strategy for the Manufacture, Allocation, and
Distribution of Drug Products, Drug Substances, and Associated Medical
Devices to respond to COVID-19, the Plan of Action to Establish a
National Strategy for the Manufacture, Allocation, and Distribution of
Medical Devices to respond to COVID-19, and the Plan of Action to
Establish a National Strategy for the Manufacture, Allocation, and
Distribution of Medical Gases to respond to COVID-19--were
finalized.\6\ These plans of action established several sub-committees
under the Voluntary Agreement, focusing on different aspects of each
plan of action.
---------------------------------------------------------------------------
\6\ See 86 FR 27894 (May 24, 2021). See also 86 FR 28851 (May
28, 2021).
---------------------------------------------------------------------------
On October 15, 2021, the sixth plan of action under the Voluntary
Agreement--the Plan of Action to Establish a National Strategy for the
Coordination of National Multimodal Healthcare Supply Chains to Respond
to COVID-19--was finalized.\7\ This plan of action established several
sub-committees under the Voluntary Agreement, focusing on different
transportation categories.
---------------------------------------------------------------------------
\7\ See 86 FR 57444 (Oct. 15, 2021).
---------------------------------------------------------------------------
The meetings are chaired by the FEMA Administrator's delegates from
the Office of Response and Recovery (ORR) and Office of Policy and
Program Analysis (OPPA), attended by the Attorney General's delegates
from the U.S. Department of Justice, and attended by the Chairman of
the Federal Trade Commission's delegates. In implementing the Voluntary
Agreement, FEMA adheres to all procedural requirements of 50 U.S.C.
4558 and 44 CFR part 332.
Meeting Objectives: The objectives of the meetings are as follows:
1. Convene the Sub-Committee to Define Requirements under the
National Multimodal Healthcare Supply Chains Plan of Action to
establish priorities related to the COVID-19 response under the
Voluntary Agreement.
2. Gather Sub-Committee Participants and Attendees to ask targeted
questions for situational awareness.
3. Identify pandemic-related supply chain issues, information gaps,
and areas for potential additional discussion.
4. Identify potential Objectives and Actions which correspond to
Sub-Committees. These will be held for further discussion under those
Sub-Committees.
Meetings Closed to the Public: By default, the DPA requires
meetings held to implement a voluntary agreement or plan of action be
open to the public.\8\ However, attendance may be limited if the
Sponsor \9\ of the voluntary agreement finds that the matter to be
discussed at a meeting falls within the purview of matters described in
5 U.S.C. 552b(c), such as trade secrets and commercial or financial
information.
---------------------------------------------------------------------------
\8\ See 50 U.S.C. 4558(h)(7).
\9\ ``[T]he individual designated by the President in subsection
(c)(2) [of section 708 of the DPA] to administer the voluntary
agreement, or plan of action.'' 50 U.S.C. 4558(h)(7).
---------------------------------------------------------------------------
The Sponsor of the Voluntary Agreement, the FEMA Administrator,
found that these meetings to implement the Voluntary Agreement involve
matters which fall within the purview of matters described in 5 U.S.C.
552b(c) and the meetings are therefore closed to the public.
Specifically, these meetings may require participants to disclose
trade secrets or commercial or financial information that is privileged
or confidential. Disclosure of such information allows for meetings to
be closed to the public pursuant to 5 U.S.C. 552b(c)(4).
The success of the Voluntary Agreement depends wholly on the
willing participation of the private sector participants. Failure to
close these meetings to the public could reduce active participation by
the signatories due to a perceived risk that sensitive company
information could be released to the public. A public disclosure of a
private sector participant's information executed prematurely could
reduce trust and support for the Voluntary Agreement.
A resulting loss of support by the participants for the Voluntary
Agreement would significantly hinder the implementation of the Agency's
objectives. Thus, these meeting closures are permitted pursuant to 5
U.S.C. 552b(c)(9)(B).
Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2021-28596 Filed 1-5-22; 8:45 am]
BILLING CODE 9111-19-P